Tempus AI Basic EPS 2023-2025 | TEM

Tempus AI annual/quarterly basic eps history and growth rate from 2023 to 2025. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
  • Tempus AI basic eps for the quarter ending March 31, 2025 was $-0.40, a 72.79% decline year-over-year.
  • Tempus AI basic eps for the twelve months ending March 31, 2025 was $-5.16, a 11.45% increase year-over-year.
  • Tempus AI annual basic eps for 2024 was $-0.006B, a 48.33% increase from 2023.
  • Tempus AI annual basic eps for 2023 was $-0.004B, a 20.75% decline from 2022.
  • Tempus AI annual basic eps for 2022 was $-0.005B, a 0% decline from .
Tempus AI Annual Basic EPS
2024 $-6.23
2023 $-4.20
2022 $-5.30
Tempus AI Quarterly Basic EPS
2025-03-31 $-0.40
2024-12-31 $2.56
2024-09-30 $-0.46
2024-06-30 $-6.86
2024-03-31 $-1.47
2023-12-31 $-1.06
2023-09-30 $-1.03
2023-06-30 $-1.07
2023-03-31 $-1.04
2022-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $11.164B $0.693B
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $47.456B 60.38
Hims & Hers Health (HIMS) United States $12.904B 134.07
Doximity (DOCS) United States $11.414B 52.84
IRhythm Technologies (IRTC) United States $4.284B 0.00
Inspire Medical Systems (INSP) United States $3.801B 59.38
Hinge Health (HNGE) United States $3.571B 0.00
Privia Health (PRVA) United States $2.402B 164.21
10x Genomics (TXG) United States $1.737B 0.00
Schrodinger (SDGR) United States $1.631B 0.00
Phreesia (PHR) United States $1.585B 0.00
Azenta (AZTA) United States $1.576B 73.26
Enovis (ENOV) United States $1.573B 8.77
Clover Health Investments (CLOV) United States $1.545B 0.00
Omnicell (OMCL) United States $1.324B 23.36
Evolent Health (EVH) United States $1.166B 99.30
Claritev (CTEV) United States $0.652B 0.00
Fulgent Genetics (FLGT) United States $0.559B 0.00
Standard BioTools (LAB) United States $0.532B 0.00
Veradigm (MDRX) United States $0.503B 0.00
Butterfly Network (BFLY) United States $0.487B 0.00
Talkspace (TALK) United States $0.421B 125.75
TruBridge (TBRG) United States $0.353B 783.33
Outset Medical (OM) United States $0.328B 0.00
Health Catalyst (HCAT) United States $0.270B 0.00
Nyxoah SA (NYXH) Belgium $0.258B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.240B 0.00
CapsoVision (CV) United States $0.185B 0.00
Zepp Health (ZEPP) Netherlands $0.161B 0.00
KORU Medical Systems (KRMD) United States $0.160B 0.00
American Well (AMWL) United States $0.140B 0.00
Pulmonx (LUNG) United States $0.134B 0.00
EUDA Health Holdings (EUDA) Singapore $0.118B 0.00
MDxHealth SA (MDXH) Belgium $0.118B 0.00
CareCloud (CCLD) United States $0.104B 3.95
ImmunoPrecise Antibodies (IPA) Canada $0.099B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.083B 0.00
111 (YI) China $0.063B 0.00
P3 Health Partners (PIII) United States $0.052B 0.00
HeartBeam (BEAT) United States $0.043B 0.00
Zhongchao (ZCMD) China $0.026B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
MSP Recovery (MSPR) United States $0.008B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00